Pfizer Withdraws EUA Application for COVID Shot in India After Regulator Asks for Independent Safety Study
![Pfizer's BNT162b2 biologic](https://staging.thevaccinereaction.org/wp-content/uploads/2022/02/BNT162b2.jpg)
Pfizer, Inc. has withdrawn its emergency use authorization (EUA) application for its experimental BNT162b2 (also known as “Comirnaty”) messenger RNA (mRNA) COVID-19 biologic (developed in collaboration with Germany’s BioNTech) in India.1 Pfizer was the first pharmaceutical company to apply for an EUA to distribute a COVID biologic in India in 2021. However, India’s regulatory agency […]